ArticleCPT: pharmacometrics & systems pharmacology2024

Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemab.

Kenta Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.